Langerød A - Search Results

1

Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.

Russnes HG, Vollan HKM, Lingjærde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL. Russnes HG, et al. Among authors: langerod a. Sci Transl Med. 2010 Jun 30;2(38):38ra47. doi: 10.1126/scitranslmed.3000611. Sci Transl Med. 2010. PMID: 20592421 Free PMC article.

2

BRCA1 screening in patients with a family history of breast or ovarian cancer.

Arver B, Claro A, Langerød A, Børresen-Dale AL, Lindblom A. Arver B, et al. Among authors: langerod a. Genet Test. 1999;3(2):223-6. doi: 10.1089/gte.1999.3.223. Genet Test. 1999. PMID: 10464672

3

High frequency of skewed X inactivation in young breast cancer patients.

Kristiansen M, Langerød A, Knudsen GP, Weber BL, Børresen-Dale AL, Orstavik KH. Kristiansen M, et al. Among authors: langerod a. J Med Genet. 2002 Jan;39(1):30-3. doi: 10.1136/jmg.39.1.30. J Med Genet. 2002. PMID: 11826021 Free PMC article.

4

The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.

Langerød A, Bukholm IR, Bregård A, Lønning PE, Andersen TI, Rognum TO, Meling GI, Lothe RA, Børresen-Dale AL. Langerød A, et al. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1684-8. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12496062

5

BUB1 infrequently mutated in human breast carcinomas.

Langerød A, Strømberg M, Chin K, Kristensen VN, Børresen-Dale AL. Langerød A, et al. Hum Mutat. 2003 Nov;22(5):420. doi: 10.1002/humu.9194. Hum Mutat. 2003. PMID: 14517964

6

Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.

Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale AL, Jeffrey SS. Zhao H, et al. Among authors: langerod a. Mol Biol Cell. 2004 Jun;15(6):2523-36. doi: 10.1091/mbc.e03-11-0786. Epub 2004 Mar 19. Mol Biol Cell. 2004. PMID: 15034139 Free PMC article.

7

Mutation of GATA3 in human breast tumors.

Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerød A, Kåresen R, Oh DS, Dressler LG, Lønning PE, Strausberg RL, Chanock S, Børresen-Dale AL, Perou CM. Usary J, et al. Among authors: langerod a. Oncogene. 2004 Oct 7;23(46):7669-78. doi: 10.1038/sj.onc.1207966. Oncogene. 2004. PMID: 15361840

8

Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.

Kristensen VN, Sørlie T, Geisler J, Langerød A, Yoshimura N, Kåresen R, Harada N, Lønning PE, Børresen-Dale AL. Kristensen VN, et al. Among authors: langerod a. Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):878s-83s. Clin Cancer Res. 2005. PMID: 15701881 Review.

9

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

Olivier M, Langerød A, Carrieri P, Bergh J, Klaar S, Eyfjord J, Theillet C, Rodriguez C, Lidereau R, Bièche I, Varley J, Bignon Y, Uhrhammer N, Winqvist R, Jukkola-Vuorinen A, Niederacher D, Kato S, Ishioka C, Hainaut P, Børresen-Dale AL. Olivier M, et al. Among authors: langerod a. Clin Cancer Res. 2006 Feb 15;12(4):1157-67. doi: 10.1158/1078-0432.CCR-05-1029. Clin Cancer Res. 2006. PMID: 16489069

10

Discovery and validation of breast cancer subtypes.

Kapp AV, Jeffrey SS, Langerød A, Børresen-Dale AL, Han W, Noh DY, Bukholm IR, Nicolau M, Brown PO, Tibshirani R. Kapp AV, et al. Among authors: langerod a. BMC Genomics. 2006 Sep 11;7:231. doi: 10.1186/1471-2164-7-231. BMC Genomics. 2006. PMID: 16965636 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page